Clinical Trial Update: The Nintedanib in Progressive Pneumoconiosis Study (NiPPS): a Collaborative NSW Treatment Trial [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for nintedanib in progressive pneumoconiosis (NiPPS) is ongoing; status is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asbestosis
• Pneumoconiosis
• Silicosis

Drugs mentioned

• Nintedanib (nintedanib)

Snippet

Sponsor: Holdsworth House Medical Practice | Conditions: Pneumoconiosis Coal, Asbestosis | Phase 2 | Status: UNKNOWN